Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Genetics and hormones cause hair loss; finasteride treats it safely.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Parietal scalp area has lower hair density and smaller hair diameter in women with hair loss.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Follicular red dots may be a normal feature seen in people with less skin pigmentation, not necessarily indicating a scalp disorder.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

Androgens can both increase body hair and cause scalp hair loss.

LLLT is a safe, promising hair loss treatment, but more research needed.

FUE and SMP together can effectively treat hair loss, needing fewer procedures.

The document concludes that understanding hair loss and considering medical treatments like minoxidil and finasteride before surgery is important, especially for young patients with rapid hair loss, and that hairline design varies among different ethnicities.

Minoxidil promotes hair growth but exact mechanism is unknown.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Mesotherapy and platelet-rich plasma treatments may help with hair loss, but their safety and effectiveness are still uncertain.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Low SULT activity in hair follicles leads to better response to oral minoxidil for hair loss.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

SFRP2 and PTGDS may be key factors in female hair loss.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Non-invasive methods can effectively diagnose and manage alopecia areata.